The goal of this study is to measure left ventricular stroke volume (SV) from the brachial artery (BA) using electrical bioimpedance. Doppler-derived SV was used for comparison. Twenty-nine healthy adults were recruited for study. Doppler echocardiographic-derived SV was obtained from the product of distal left ventricular outflow tract cross-sectional area and systolic velocity integral. SV from the BA was obtained by transbrachial electrical bioimpedance velocimetry (TBEV). Application of a current field across the left brachium was effected by injection of a constant magnitude, high frequency, low amperage, alternating current. Therein, a static voltage (U 0 ) and pulsatile voltage change ( U(t)) were measured and converted to their corresponding impedances, Z 0 and Z(t). TBEV-derived SV was obtained by multiplying a square root value of the normalized, acceleration-based, peak first time derivative of Z(t) by a volume conductor and systolic flow time. Inter-method agreement was determined by the Bland-Altman method. To assess the contribution of blood resistivity variations to Z(t), BA diameters were measured at end-diastole and peak systolic expansion. Results indicate that since the BA demonstrates parabolic, laminar flow, with minimal diameter changes, blood resistivity variations are likely responsible for the derived impedance changes. BlandAltman analysis shows that SV is obtainable by TBEV from healthy humans at rest.
Introduction
Cardiac output (CO, ) is the ultimate expression of cardiovascular performance. Stated otherwise, over the full spectrum of hemodynamic perturbations and metabolic requirements, the magnitude of potentially recruitable combinations of heart rate and stroke volume (SV, mL) determines the efficiency of the heart as a muscular pump (Christie et al 1987) . The measurement of CO is important because it is the dynamic variable defining the adequacy of oxygen transport and the centerpiece of goal-oriented therapeutic strategy in critically ill patients (Pinsky 2007, Pugsley and Lerner 2010) .
As a veiled challenge to the scientific community, Donald A McDonald stated, 'The discovery of a technically simple and nontraumatic way of estimating the output of the heart per beat is something of an El Dorado' (Kouchoukos et al 1970) . Over the past half-century, many attempts have been made to satisfy the requirements of an ideal CO method. Some of the more important requirements are given in table 1 (de Waal et al 2009) .
Apart from the continuous Penaz-Wesseling-inspired fusion of pulsatile unloading of the finger arterial walls with a three-element windkessel model (Alhashemi et al 2011 , Stover et al 2009 and various electrical bioimpedance techniques, there are no clinically applicable methods that are truly noninvasive, continuous, technician-independent, and 'hands-off' (Lee et al 2011 , Funk et al 2009 , Moshkovitz et al 2004 . While many CO measurement techniques are available (Alhashemi et al 2011) , few, including the so-called gold-standards, provide consistently satisfactory SV and CO agreement when compared to one another in critically ill humans (Peyton and Chong 2010 , Sherman et al 1997 , Baylor 2006 , Axler et al 1996 . All methods, including the current clinical 'gold-standard', thermodilution, are beset with inherent errors, which frequently preclude close agreement with other techniques in the hemodynamically unstable patient (Peyton and Chong 2010 , Nishikawa and Dohi 1993 , Reuter et al 2010 , Bazaral et al 1992 , Heerdt et al 2001 , Tournadre et al 1997 . The purpose of this study is to introduce a new electrical bioimpedance method, transbrachial electrical velocimetry (TBEV), which measures SV by electrical interrogation of the brachial artery (BA). Theoretical and operational justification for the technique requires a basic review of transthoracic electrical bioimpedance (TEB).
Background and theoretical concerns
1.1.1. SV by means of TEB technique. Impedance cardiography (ICG), also known as TEB cardiography, and historically as impedance plethysmography (IPG, ZPG) (Nyboer 1950) , is a noninvasive, continuous, 'hands-off' technology, which is primarily concerned with the determination of left ventricular SV (Kubicek et al 1966 , Bernstein and Lemmens 2005 , Bernstein 2010 , Gujjar et al 2008 . The details of this heavily researched method are found abundantly elsewhere (Summers et al 2003) , but major controversies still surround the magnitude and biometric variables involved in obtaining the volumetric constant of proportionality, and the biophysical origin and interpretation of the transthoracic, cardiogenically induced, time-dependent impedance change, delta Z ( Z(t), ohm, ) and its peak first time-derivative, dZ(t)/dt max (Bernstein and Lemmens 2005 , 2007 , Bernstein 2010 . While ICG equations abound (Moshkovitz et al 2004) , all rely upon one simple relationship, namely that SV is proportional to the product of a volumetric constant V (mL) and the normalized maximum calculated impedance change ( Z max /Z 0 ) generated within a current field to an applied alternating current (ac) (Nyboer 1950 , Moshkovitz et al 2004 : For equation (1), Z 0 is the quasi-static dc component of the impedance of a body segment within the current field.
Limitations of TEB-derived SV.
It is generally agreed that ICG meets the majority of criteria for an ideal CO method (de Waal et al 2009) (table 1) . However, despite its many attributes, objections to ICG's general introduction into mainstream clinical medicine are principally due to its unpredictable accuracy in patients with severe heart disease, and in those who are critically ill (Raaijmakers et al 1999) . A major limitation is ICG's well-documented tendency to systematically underestimate SV/CO in the presence of pathologic increases in extravascular lung water, such as in congestive heart failure and sepsis (Kamath et al 2009 , Critchley et al 2000 , Raaijmakers et al 1998 . Other problems surround the on-going controversy concerning the anatomic and physiological source of dZ/dt, and especially the validity of dZ/dt max as a true representative of peak aortic blood flow (Q max , mL s
) (Wang and Patterson 1995 , Kosicki et al 1986 , Kauppinen et al 1998 , Trakic et al 2010 . A major source of error in SV calculations is no doubt caused by contributions from multiple arterial and venous signals, amalgamated into one waveform (Wang and Patterson 1995 , Kosicki et al 1986 , Kauppinen et al 1998 , Trakic et al 2010 . Thus, at any instant in the cardiac cycle, dZ/dt is an intensity-weighted mean of an ensemble of impedance changes occurring simultaneously and originating from diverse origins.
Origin of dZ/dt max by differential and comparative time-domain analysis.
A principal cause for poor agreement with reference standards of flow may be due to misinterpreting the origin of dZ/dt max . While generally ascribed the dimensional units of s −1 , implying a flow velocity analog, this, through rigorous biophysical scrutiny, may not be true when the waveform is analytically dissected. It is well known that transthoracic Z(t) is of dual origin (Visser 1989 , Visser et al 1990 , Sakamoto and Kanai 1979 , comprising a velocity-induced component, related to changing blood resistivity ( Z VEL (t), s −1 ), and a volumetric component, related to great thoracic vessel expansion and recoil, displacing broncho-alveolar gas ( Z VOL (t), (t)). As determined through in vitro experiments, it is customary to consider the velocity-induced resistivity component a trivial contaminant, leaving the volumetric component as the sole origin of Z(t) (Kubicek et al 1966 , Peura et al 1978 , Ravi Shankar et al 1985 , Wtorek and Polinski 2005 .
However, assuming the velocity component is not trivial, in vivo (Visser 1989 , Visser et al 1990 , Sakamoto and Kanai 1979 , Kosicki et al 1986 , consider the following argument. An equation allied to Ohm's law suggests that for an electrically conductive, cylindrical, blood-filled vessel of length L (cm) and internal blood volume V b (mL) with static specific resistance of blood ρ b ( cm), the static impedance Z across the length of the vessel to an applied ac field in end-diastole is
Assuming this vessel is the ascending aorta, embedded within the thorax, ventricular ejection imparts a velocity (v, cm s −1
) to the blood, reducing its time-dependent specific resistance (resistivity) (↓ ρ b (t), cm s −1 ), and increasing its conductivity (↑ σ b (t), σ s
−1
). Simultaneously, the pressure-dependent cross-sectional area increases during early to mid ventricular systole, generating a time-dependent reduction in transthoracic specific resistance, (↓ ρ T (t)). If the respiratory component ( Z RESP (t)) of the transthoracic impedance (Z(t)) is suppressed, then the volumetric component of ρ T (t) ∝ V (GAS) (t)/ V (BLOOD) (t), where ρ (GAS) = 10 20 cm and ρ (BLOOD) = 100-180 cm. Thus, composite Z(t) is given as
Accordingly, with reference to equation (2), the change of vessel impedance ( Z(t)) ascribed to velocity changes ( Z (VEL) (t)) during ejection can be expressed as follows:
where equation (4) represents ohmic velocity ( s −1 ). Analogously, the impedance change ascribed to CSA changes over constant length
where equation (5) is expressed in ohms ( ). Combining equations (4) and (5) produces a composite expression, encompassing ohmic velocity and time-dependent ohmic change in volume:
Equation (6) illustrates the concept of a composite origin for Z(t), where Z(t) is represented by both velocity and volumetric components, which are expressed in s −1 and , respectively. As is obvious, the dimensions of Z(t) cannot be uniquely ascribed to either component, but rather a combination of both. If equation (6) is differentiated by parts with respect to time, and L is considered a constant, the following results for composite dZ/dt:
For equation (7), derivatives 1 and 2 represent, respectively, ohmic mean acceleration ( s −2 ) and ohmic mean flow velocity ( s −1 ). Deconstructing equation (7) to find the origin of the derivatives, dρ b (t)/dt is the time rate of change of the specific resistance of flowing blood, which is ohmic acceleration ( cm s ). Despite equation (7) delineating the derivative components of dZ/dt, there is no information encoded within either derivative regarding the origin of dZ/dt max . As thoroughly discussed by Lemmens (2005, 2007) and Bernstein (2010) , it has been found that dZ/dt max peaks precisely in the time domain of peak aortic blood acceleration (dv/dt max , cm s ) (50 ± 20 ms) and not with peak velocity or flow (dV/dt max , mL s −1 ) (100 ± 25 ms). As an affirmation, dZ/dt max peaks precisely in time with aortic ), which in turn peaks with peak aortic blood flow acceleration (π r 2 dv/dt max = dQ/dt max , mL s −2 ) (Bernstein 2010, see figures 1, 6 and 7). Therefore, it is suggested that dZ/dt max is an ohmic acceleration analog and is given thusly: By definition, impedance, Z is a complex quantity. This means that it is described thusly: Z = |Z|e jθ for all |t| < ∞, where the magnitude |Z| represents the ratio of the voltage difference amplitude to the current amplitude. The exponents, θ and j, represent the phase difference and the imaginary unit, respectively, for all times t. Therefore, by definition and strictly speaking, Z cannot be a time-varying function. However, systems that exhibit time-varying voltage-current ratios, which appear to be time invariant for small observation windows, can be roughly described as having a time-varying Z (i.e. Z(t)). For the purposes of the authors' argument, the notation
, where V(t) is the time-varying ratio of alveolar gas volume to intrathoracic blood volume and v is the axial blood velocity. It is important to note that Z is varying with (function of) the velocity and volume of blood for a given instant, but not with time itself. By historical convention, when v is assumed to be trivial,
, and is assigned the unit , and it is implicitly understood that it is the changing volume that is a function of time, not the impedance directly. As per the major thesis of this paper, for TBEV Z[ f (V(t))] is considered negligible, and thus
, and is ascribed the units, s
. As the derivative of velocity is acceleration, it therefore follows that dZ/dt max is legitimately ascribed the units of s −2 . Once again, it is implicitly understood that the Z is varying with acceleration and not time, per se. Thus, the implication that Z is time variable is only correct when a time-varying function is changing, independent of the impedance itself. Since Z is not a time-varying function, it is always implicitly understood to imply variation of another 'hidden' time-dependent quantity.
Thus, and in concordance with dimensional units for equation (8), to reduce ohmic mean acceleration to ohmic mean velocity, the variable necessary for SV calculation, square root transformation of the ratio, dZ/dt max /Z 0 must be obligatorily performed:
1.1.5. Rationale for a mass-based volume conductor in ICG. As opposed to volumetric constants of proportionality, based on thoracic length L (cm), as derived from equation (2) (Moshkovitz et al 2004) , the method appropriate for values of ohmic mean velocity obtained from equations (8) and (9) requires a significantly smaller volume conductor (V C ). The V C , otherwise known as the volume of electrically participating thoracic tissue (V EPT , mL) (Bernstein 1986 ), scaled appropriately for equation (9), derives its rationale from the linear relationships and high correlations obtained for body weight (kg) and total blood volume (TBV, mL) (Feldschuh and Enson 1977, Lindstedt and Schaeffer 2002) , body mass and SV (Holt et al 1968 , Collis et al 2001 , TBV and intrathoracic blood volume (ITBV, mL)(LichtwarckAschoff et al 1992), ITBV and global end-diastolic volume (GEDV, mL) (Nirmalan et al 2005) , and change in ITBV and GEDV index with change in the SV index (Bindels et al 2000 , Della Rocca et al 2002 , Michard et al 2003 , Rex et al 2004 . It is important to note that the latter two volumes are the most powerful determinants of preload and thus SV. Thus, V EPT , appended to equation (9), is conceptualized physiologically and by magnitude, as the ITBV; this results in V EPT ≡ V ITBV . By magnitude, the ITBV is approximately 25% of TBV, and when indexed to body surface area, 750-800 mL m −2 (Rex et al 2004) . If the normal indexed blood volume ∼ = 70 mL kg −1 (Feldschuh and Enson 1977) this implies that the indexed ITBV = 0.25 × 70 = 17.5 mL kg −1 (Hofer et al 2002) which, according to allometric convention is approximated by 16W
1.02 . This transformation of weight into an equivalent volume is completely valid, because the density (ρ) of blood approximates unity (1.05 g mL
). Confirmation of the rationale for employing weight rather than height as the personal constant resides with the correlation of TBV with weight, which is between r = 0.88 and 0.77, for men and women, respectively, versus that between TBV and height, which is between r = 0.35 and 0.37, for men and women, respectively (Feldschuh and Enson (1977) . Thus, as opposed to linear-based volume conductors, using thoracic length L or height-based thoracic length equivalents (Kubicek et al 1966 , Bernstein 1986 ), V ITBV is biophysically assumption-free, inherently unambiguous in physiologic meaning, and is intuitively understood as the physical embodiment of the blood resistance (i.e. R b ≡ ITBV≡ V EPT ) (Bernstein and Lemmens 2005) .
When the rhs of equation (9) 
where V C(TEB) is the volume of electrically participating thoracic tissue, allometrically equivalent by body mass to the intra-thoracic blood volume = 16W 1.02 = mL, dZ/dt max is the peak time rate of change of the transthoracic impedance pulse variation = s −2 , Z 0 is the the quasi-static transthoracic base impedance = and T LVE is the left ventricular ejection time s.
While some studies using equation (10) 
Transbrachial electrical velocimetry
The goal of this study is to show that electrical bioimpedance data, transduced noninvasively from the BA using TBEV, can be used to calculate an estimate of left ventricular SV, implementing a modified version of equation (10). Due to the rigid, muscular nature of the BA, it is also suggested that the downstream, cardiogenically induced translocated impedance change represents a nearly pure blood resistivity signal.
It is hypothesized that the electrical principles and basic operational implementation of the transthoracic technique are directly applicable to BA measurements of SV. The fundamental rationale for the transbrachial approach derives from the direct proportionality and high correlation (r = 0.79) observed between peak ascending aortic blood acceleration and peak BA blood flow acceleration (i.e. aortic dv/dt max ∝ brachial dv/dt max (cm s −2 ) (Chemla et al 1996) . As discussed by Lemmens (2005, 2007) and Bernstein (2010) (vide supra) , waveform analysis shows that dZ/dt max also peaks in the time domain of ascending aortic dv/dt max . Thus, analogous to the study of Chemla et al (1996) , it is suggested that ascending aortic dv/dt max is proportional to transbrachial dZ/dt max (i.e. aortic dv/dt max ∝ brachial dZ/dt max ). Further inspiration for pursuing this theory was compounded by the observation that transbrachial dv/dt max is only affected by β 1 stimulation of the myocardial adrenoceptors and not by downstream, peripheral vasoactivity (Chemla et al 1990) .
Methods
The study population for TBEV validation consisted of 29 volunteer subjects, comprising 18 males and 11 females. All were free of demonstrable cardiopulmonary disease. Regular sinus rhythm was present in all 29 subjects. Subject demographics are shown in table 2. This study was approved by the institutional review board of Aspire IRB, San Diego, CA. Informed, oral and written consent were obtained from each subject. SV obtained by the TBEV approach was compared to two-dimensional (2D) echocardiography with pulsed Doppler velocimetry of the left ventricular outflow tract (LVOT). Continuous color-flow Doppler images were obtained to assess BA diameters, change in diameter and flow patterns during the cardiac cycle.
Data collection and study design
This is a prospectively designed study for measuring SV; all parameters of the TBEV equation were set prior to data collection. TBEV electrodes were applied to each subject as shown in figure 1, after which a 10 min stabilization period was observed before any data collection. Due to positioning considerations, Doppler/echocardiographic data were obtained sequentially rather than simultaneously. TBEV-derived SV was obtained from the mean value of data collection before and after the Doppler/echo SV study. Each echocardiographically obtained BMI = body mass index, BSA = body surface area, SBP = systolic blood pressure, DBP = diastolic blood pressure, MAP = mean arterial pressure, HR = heart rate.
Results in mean ± SD and range.
SV represented the mean of at least ten (10) acceptable sequentially obtained velocity time integrals and a single measurement of LVOT diameter. Satisfactory acoustic windows were obtained in all 29 subjects.
Echocardiographic-derived SV
Evaluation of the echocardiographic SV was performed using standard pulsed Doppler and tissue harmonic 2D image data (Dubin et al 1990 , Quinones et al 2002 , Otto 2009 . A Philips SONOs 5500 with D.0 software and transducer s3 was employed. Doppler measurements were performed with a frequency of 0.6 MHz and a small sample volume. Image frames and loops and representative measurements were stored in an optical disk. According to ASE guidelines and recommendations (Quinones et al 2002 , Otto 2009 ), the measurement of SV was performed by interrogation of the LVOT, just proximal to the aortic valve leaflets. The LVOT diameter was measured in the parasternal long-axis view, parallel to and just below the aortic valve in the mid-systole. Pulsed Doppler of the LVOT peak, outer envelope (maximal) velocities (cm s −1 ) were integrated over LVET to obtain the systolic (time) velocity integral (SVI, TVI, cm) (Dubin et al 1990) . SVI measurements were performed in the apical four-chamber view at the same site as the LVOT diameter. SV was obtained from the LVOT by the following equation:
where D (cm) is the diameter of the LVOT proximal to the aortic valve leaflets and the integral is the systolic or time velocity integral (cm). Table 3 provides the variables involved with Doppler/echo-derived SV.
BA interrogation by 2D imaging and pulsed wave Doppler velocimetry
The left BA imaging study employed the Philips 5500, D.0 software, using the 11-3 MHz ultraband vascular linear array transducer.
2.3.1. 2D imaging of the BA. Subjects were imaged in both the supine and left lateral positions with the left arm in a comfortable position for imaging the BA. Satisfactory interrogation of 
PW Doppler.
A pulsed wave Doppler recording was obtained from the mid-artery by placing the PW spectral Doppler sample volume in the center of the vessel with the arrow angle pointing 60 o toward the direction of flow and parallel to the walls of the artery. The spectral PW Doppler image was frozen, and then digitally stored onto the ultrasound system hard drive.
Measurements.
Boundaries for the BA diameter (D BA ) measurements in the selected images (lumen intima or media-adventitia interfaces) were obtained by saving an image composed of a sequence of frames, sampled at 29 Hz, over several cardiac cycles. The images were then post-processed on a personal computer to enhance artery boundaries, and a rectangular region of interest (ROI), encompassing both the upper and lower walls of the artery, was selected manually for each image. The inner edge of the artery walls were then identified using the Hough transform, and the average distance between the edges computed over the ROI. The image enhancement, edge extraction and diameter measurement were then applied automatically to each frame of the image to obtain a time series of average diameters within the ROI. Diameters were measured from end-diastole to peak systolic expansion using electrocardiographic gating (figure 2, table 4). 
TBEV-determined SV and CO

Data collection.
TBEV data were obtained from a custom analog circuit generating a voltage output that was digitized in real time using a BIOPAC UIM100C system (BIOPAC, Goleta, CA, USA), and then stored on a personal computer (Sotera Wireless, San Diego, CA, USA). All waveforms were sampled at 16-bit resolution and 500 Hz. The system was powered with a 12 V battery to remove any 60 Hz common mode artifacts. Satisfactory TBEV signals were obtained from 28 of 29 subjects.
The TBEV device was interfaced with a four-lead electrode montage (3M, Red Dot TM , 3M Health Care, Neuss, Germany) applied to the brachium (figure 1). The left arm was chosen for electrical interrogation, because of direct anatomic continuity of the left subclavian artery with the aortic arch. Operationally, two current driver electrodes were placed, one medially in the axilla and one distally at the antecubital fossa. Two voltage sensors were placed proximate the current drivers, spaced-apart approximately 5 cm and within the current field. The injected ac was modulated at 70 kHz and featured a constant magnitude of 4 mA rms. The voltage measured between the sensing electrodes was amplitude-demodulated by rectification and filtering. The raw voltage signal was split and processed, with a high pass filter with a cutoff frequency of 0.1 Hz to obtain the change in voltage ( U(t)) and a low-pass filter with cutoff frequency of 10 Hz to obtain the quasi-static voltage (U 0 ). The raw ac and dc voltages were converted to the corresponding impedances (Z) by Ohm's law.
Digital signal processing was applied to Z(t) in order to remove low-and high-frequency noise from the derivative, dZ/dt. For each subject, the TBEV dZ/dt signals were averaged over the measurement cycle to obtain a mean dZ/dt max ; corresponding fiducial landmarks were identified to compute a mean T SF (figure 3). (V C(Brachium) ). In order that SV obtained by the TBEV technique be equivalent to the transthoracic ICG method, the following relationship was established as an abstract implementation of the equation of continuity for conservation of mass flow:
Determination of the transbrachial volume conductor
where V C(TEB) = V C(Brachium) .
In an unpublished pilot study of 38 subjects, rearranging equation (12) and solving for V C(Brachium) produced a V C ∼twice that of the transthoracic V C(TEB) . Using the same experimental protocol as for the TBEV versus Doppler/echo study, impedance measurements were obtained from the transthoracic approach as well as transbrachially. To obtain transthoracic dZ/dt max and Z 0 , a commercially available impedance cardiograph (Lifegard II, Analogic Corp., Peabody, MA, USA) was used. The technique is described elsewhere in detail (Bernstein 1986, Bernstein and Lemmens 2005) . In figure 4(a) , the ratio of ohmic mean velocityv = (dZ dt max ) · Z −1 0 0.5 from the transthoracic approach and that from the transbrachial approach are compared for the 38 subjects. While the distribution is not strictly Gaussian, there appears to be a clustering of values around 2, and the mean of the values is 1.9 ± 0.3 SD. Figure 4(b) shows that ∼75% of data fall within 20% of the ratio, 2, and 95% of data fall within 30% of the ratio, 2. Satisfying the equation of continuity for conservation of mass flow from equation (12) by solving for V C(Brachium) , the coefficient for the V C was set at twice the value for the transthoracic method, thus closely approximating 32. These results are consistent with the numerous studies which show that, on the mean, the ascending aortic peak velocity is ∼90-100 cm s −1 (Wilson et al 1985 , Daley et al 1985 , Sabbah et al 1986 , Gardin et al 1984 and that of the BA is ∼ 50-60 cm s −1 (Sugawara et al 1998 , Guler et al 2000 , Green et al 2002 , yielding a ratio of ∼2. Males Females where (1) V C(Brachium) = volume conductor = 32 × W (kg) 1.02 = mL, (2) dZ/dt max = peak rate of change of the transbrachial impedance pulse variation = s 
Stoke volume determination by means of TBEV. The following equation was thus implemented:
SV TBEV = V C(TBEV) · dZ/dt max Z 0 · T SF (mL),(13)Mean ± SD (Range) Mean ± SD (Range) dZ/dt max ( s
Data analysis
An agreement between SV measured from the transthoracic Doppler-echo and TBEV techniques was obtained using the Bland-Altman method (Bland and Altman 1986) . Parameters assessed were mean bias, limits of agreement (LOA), standard deviation (SD) and percent error between the methods. Mean values and ranges for BA diameter (D, mm), change in diameter ( D, mm) and percent change in diameter ( D,%) were measured at end-diastole and peak systolic expansion (table 4) .
Results
For SV determination, mean bias between the two techniques was −4.0% (2.5 mL), standard deviation (precision) 14.7% (11.9 mL), LOA −25.4-33.4% (23.8 mL) and percent error (a) (b) Figure 5 . Bland-Altman analysis of SV showing a bias of −4.0% (2.5 mL), precision and SD 14.7% (11.9 mL), LOA −25.4% to 33.4% (23.8 mL) and percent error, 28.9% between TBEV and Doppler/echocardiographic measurements.
28.9% (figure 5). The mean BA diameter, mean change in diameter and mean percent change in diameter for males and females was 4.03 mm and 3.10 mm, 0.1 mm and 0.08 mm, and 2.36% and 2.42%, respectively (table 4).
Discussion
This is not the first study assessing SV or blood volume changes from the upper extremity with the bioimpedance technique. In a seminal paper by Nyboer (1950) , four band electrodes were placed on the forearm, and similar to the technique used in this study, quantitative blood volume changes were measured between voltage-sensing electrodes. The equations ultimately used to estimate SV by the transthoracic impedance method originated from that paper. Wang et al (2007) used a four-spot-electrode montage, analogous to the one featured in this study, but the electrodes were instead placed over the radial artery between the wrist and antecubital fossa (Wang et al 2007) . They found high correlations between change and percent change in SV obtained by 2D echocardiography with the change and percent change in both the maximum amplitude of and area beneath forearm Z(t), respectively (r = 0.78-0.86). Stanley et al (2009) obtained Z(t) from the transthoracic approach and upper and lower extremities. Waveform amplification clearly shows that the maximum systolic upslope (acceleration) from the thorax and upper extremities are identical. These results are concordant with our study and those of Chemla et al (1996) showing that dv/dt max from the ascending aorta and upper extremities are directly proportional.
Measuring SV from the acceleration of blood in the BA has obvious advantages over the transthoracic technique. First, the idealized parallel conduction model of a cylindrical blood resistance, embedded within a poorly conductive cylindrical tissue impedance, is realistically fulfilled. Second, in contrast to the ascending aorta, the BA is not corrupted by competing intra-and extrathoracic vessel pulsations. Third, whereas the vessel impedance changes obtained from the thorax have a large contribution from CSA-generated volumetric changes, the BA is muscular and poorly compliant (Chuang et al 2002 , Lott et al 2002 , Green et al 2002 . Inspection of table 4 clearly illustrates this, showing that, from end-diastole to peak systolic expansion, BA diameter remains virtually unchanged ( D = 2-3%). This finding is corroborated by Chuang et al (2002) , where they demonstrated that despite drug-induced vasodilation and reactive hyperemia, the BA pulsatile diameter varies by no more than 2-3% at any level of temporarily fixed vessel relaxation. Figure 2 demonstrates that a pressure pulseinduced change in the BA diameter occurs, but the maximum excursion is no more than 2-3% on the mean. With regard to TBEV, this finding is probably moot, considering that Chemla et al (1990) found that brachial dv/dt max is affected only by upstream β 1 adrenoceptors of the heart and not downstream vasoactivity.
Since the BA barely changes its cross-sectional area during ejection (Chuang et al 2002 , Lott et al 2002 , Green et al 2002 , it is suggested that equation (4) and derivative 1 of equation (7) contribute virtually 100% to transbrachial dZ/dt and dZ/dt max . Lack of transverse displacement of BA CSA directly implies that the transbrachial impedance signal is due almost exclusively to velocity-induced alignment of red blood cells, which in turn results in blood resistivity changes (equation (4)). Etiologically, there is overwhelming evidence that the resistivity change is due to the pulsatile flow-induced oscillating orientation of the disk-shaped erythrocytes (Hoetink et al 2004) . This hypothesis is affirmed by the demonstrated lack of resistivity change using an in vitro suspension of spherocytes subjected to pulsatile blood flow through a rigid tube (Sakamoto and Kanai 1979, Visser et al 1976) . The results obtained in this study, in vivo, closely mimic the in vitro experiments of Lamberts et al (1984) . They demonstrated that forcing a suspension of erythrocytes through a rigid tube, using pulsatile flow, produced a significant oscillatory change in impedance. When saline or stroma-free hemoglobin were perfused similarly, no impedance change was noted. Whereas ascending aortic flow may be turbulent, or at least close to turbulent, and especially in the presence of aortic valve disease Sabbah 1976, Stalder et al 2011) , flow in the BA is laminar, as reflected by the fully developed, bullet-like parabolic leading edge of the color-flow Doppler velocity signal in earliest systole (figure 6).
It is, to the authors' knowledge, the first study to pictorially demonstrate, in vivo, and in real time, the presence of a parabolic flow profile in the BA. Because of the influence of viscous forces on the orientation of erythrocytes, there is a shear rate-dependent conductivity in flowing blood (Visser 1992) . The shear rate profile is governed by two parameters: (1) the average blood velocity ( ν cm s ) and (2) the radius (R, cm) of the conduit. The quotient of ν and R is known as the reduced average velocity, also known as the spatial mean velocity ( ν /R, s −1 ) (Gaw et al 2008) . Insofar as the blood conductivity waveform is concerned, in vitro, the peak slope of ν /R dictates its maximum upslope, d( σ b (t)/σ b(stat) )/dt max during early ejection (Gaw et al 2008) 
Reprinted with permission from Gaw et al (2008 ) IEEE Trans. Biomed. Eng. 55 721-7. Copyright IEEE 2008 domain is the foundational basis for the validity of TBEV-derived SV (section 1.2). Unlike the positive acceleratory phase, the negative acceleration phase is characterized by a nonlinear decay of blood conductivity, extending to end-systole and beyond to end-diastole (figures 6 and 8(b)).
The enhanced conductivity and gradual decay is the result of the inability of the red cells to reach complete random orientation at end-systole, and is characterized by a decay constant, τ (tau). The virtual lack of a plethysmographic component in the transbrachial derivative signal accounts for the altered morphology as compared to transthoracic dZ/dt (figure 3). As figures 3(b) and 8(d) demonstrate, similar to the differentiated Doppler signal (i.e. acceleration, cm s −2 ) (figure 8(c)), termination of flow on transbrachial dZ/dt is heralded by the second zero crossing (figures 3(b) and 8(d)) after dZ/dt max . By comparison, the end of ejection on transthoracic dZ/dt manifests as the nadir after the first zero crossing after dZ/dt max ( figure 3(a) ).
Superposing the brachial Doppler velocity waveform and the brachial dZ/dt signals of figures 8(a) and (d) shows that dZ/dt max peaks prior to peak brachial flow velocity by about 50 ms. Superposition of the brachial Doppler acceleration waveform (figure 8(c)) with that of brachial dZ/dt (figure 8(d)) shows that not only are the waveforms nearly identical in morphology, but their peak values closely overlap in the time domain (figures 8(c) and (d)). This is prima facie evidence highly suggestive of brachial dZ/dt being a pure blood resistivity, acceleration-based waveform and its peak value, dZ/dt max , an ohmic analog of dv/dt max and not that of dV/dt max . It should also be noted that regardless of any changes in BA diameter, both BA dv/dt max and dZ/dt max peak in the explosive, inertial phase of earliest systole, before any volume change occurs Lemmens 2005, Bernstein 2010 ). This is confirmed by the work of Chuang et al (2002) , which showed that no diameter change was noted in the first 50 ms from the onset of flow. Biomechanically, this renders any volume change irrelevant as concerns BA dZ/dt max . In consideration of the relationship established in this study, it can be comfortably stated that the close agreement between the transthoracic Doppler and transbrachial impedance techniques is due to both being velocimetric-based technologies; the former measures a red cell velocity-induced ultrasonic frequency shift and the latter a red cell velocity-induced blood resistivity change.
Results from this study suggest that in healthy human adults at rest, TBEV and Doppler/echo estimates of SV are interchangeable according to criteria established by Critchley and Critchley (1999) . As a testament to its validity, Bland-Altman analysis of the mean bias is small, and LOA and percent error are well within the realm of clinical acceptability (Critchley and Critchley 1999) . These results are quite remarkable in view of the many potential errors and pitfalls, using 2D Doppler/echo for determination of SV (Shahgaldi et al 2010) and the assumptions of the TBEV method. It is also demonstrated that since BA diameter changes trivially over the entire cardiac cycle, and especially during peak systole, the TBEV impedance signal is generated almost completely by changes in blood velocity.
Limitations of the study
First, the study population was small and restricted to otherwise healthy individuals at rest. Despite satisfactory agreement between TBEV and Doppler/echo estimates of SV, the reference method is by no means a standard by which validity of the TBEV approach can be ensured (Shahgaldi et al 2010) . Secondly, the means by which the transbrachial V C was obtained in the pilot study is prone to errors. Specifically, the impedance variables collected from the commercially available ICG machine in the pilot study could not be verified by independent signal processing. Thus, it is unknown what degree of error was imparted to the values of transthoracic dZ/dt max and Z 0 . The measurements of transbrachial dZ/dt max and Z 0 were obtained from an experimental circuit via the BIOPAC (vide supra), where results were verifiable; but the signal quality not optimal. It is also to be noted that the distribution of mean velocity ratios in figure 4(a) is not Gaussian, which may be due to second order magnitude variables, such as gender, circumference of the brachium, and diameter of the BA. Moreover, our pilot study may have been inadequately powered. Because the full gamut of possible input variables for V C(Brachium) have not been definitively identified, the theory behind the conductor is not scientifically confirmed. Clearly, further studies are required. Technical and theoretical details aside, in various shock states there is redistribution of CO away from non-essential vascular beds and it is not known what effect this will have on the parallel relationship between peak aortic and peak brachial dv/dt (Forsythe et al 1970 , Slater et al 1973 . Despite the work of Chemla et al (1990) , it is also not known how BA flow-mediated vasodilation will affect the accuracy of SV measurement. Mechanical factors affecting accuracy include subclavian/BA stenosis, and upper extremity arteriovenous shunts for hemodialysis. Although conjectural, spurious results may result from edema of the upper arm by a similar mechanism to that observed with the transthoracic method (vide supra) (Bernstein 2010, Bernstein and Lemmens 2005) . The results from this study, therefore, cannot be directly extrapolated to a similar agreement with 'gold-standard' methods in the cardiac patient or those who are critically ill. Operationally, the impedance signal from the brachium is extremely motion sensitive, which may limit its global applicability, especially with exercise. Electrical noise, most notably during electrocautery in the operating room, as well as radio frequency and 60 Hz interference will preclude accurate measurements.
Conclusions
In healthy patients at rest, TBEV estimates of SV/CO are equivalent to those obtained by the Doppler/echo method according to Critchley and Critchley (1999) . As compared to measurements using transthoracic ICG, the TBEV waveform is likely generated almost entirely by velocity-induced changes in blood resistivity and not vessel volume changes. This hypothesis is suggested as true because of the demonstrated BA rigidity and the presence of parabolic laminar flow. Despite possible deficiencies in the construction of the volume conductor, our results indicate that Doppler and transbrachially derived SV are more likely than not interchangeable in a supine human at rest. Most compelling, however, this study is the first to provide sound evidence of the overwhelming dominance of blood resistivity changes contributing to absolute SV determination by the bioimpedance technique.
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